Clinical Trial Update: Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy [NA]

View source ↗

Summary

Dana-Farber Cancer Institute's trial evaluating lymph node assessment after neoadjuvant chemotherapy for breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | NA | Status: WITHDRAWN